ClinicalTrials.gg
RecruitingNCT04176562SPINEUpdated Mar 12, 2024

Prospective SPINE Registry

An observational study in Sacroiliac; Fusion, Sacroiliac and Joint Diseases, sponsored by Xtant Medical. Recruiting at 12 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-12.

Sponsored by Xtant Medical · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Study summary

This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.

02

Conditions studied

  • Sacroiliac; Fusion
  • Sacroiliac
  • Joint Diseases
  • Musculoskeletal Diseases
  • Spinal Disease
  • Spinal Stenosis
  • Spinal Instability
  • Fusion of Joint
  • Fusion of Spine
  • Spinal Fusion
  • Spine
03

In context

Joint Diseases

386 studies on the registry are indexed under Joint Diseases; 64 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 86 across 116 observational studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Xtant Medical is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients that have spinal problems requiring treatment with an RTI Surgical spine product.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Candidate for RTI spine product.
  2. Willing and able to consent to the study.

Exclusion criteria

Exclusion Criteria:

  1. Patient who is, or is expected to be inaccessible for follow-up.
  2. Patient meets any exclusion criteria required by local law (e.g. age, mental capacity, etc.).
  3. Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligible for the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • DeviceRTI Spine products

    * Interbody fusion devices - intended to help facilitate fusion by providing a platform for bone growth, while maintaining height and decompression. * Supplemental fixation and/or stabilization devices - are intended to stabilize the spine to allow for fusion to occur, maintain current spinal movement, correct deformities or curvature, treat trauma, spinal stenosis, tumor and pseudarthrosis. * Bone graft substitute - is intended to aid in fusion.

06

What researchers measure

Primary outcomes

  1. Intervention Rates

    Rates of reoperation and/or revision procedures at index level

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

Secondary outcomes

  1. Fusion

    Fusion success measures by radiological assessment (x-ray, CT scan, MRI, etc.)

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  2. Radiographic Findings

    Change in radiographic findings

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  3. Adverse Events

    Number of procedure and device related adverse events

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  4. Disability (Cervical)

    Change in Neck Disability Index

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  5. Disability (non-Cervical)

    Change in Oswestry Disability Index

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  6. Pain Change

    Change in pain as determined by Visual Analogue Scale (VAS)

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

  7. Time to Intervention

    Time to first reoperation and/or revision procedure at index leve

    Time frame: 1 month, 3 months, 6 months, 12 months, and 24 months

07

Study locations

1 of 12 sites recruiting
  • Hartford Hospital
    Hartford, Connecticut 06102, United States
    Active, not recruiting

    Not enrolling at this site.

  • Florida Back Institute
    Boca Raton, Florida 33496, United States
    Active, not recruiting

    Not enrolling at this site.

  • Spine Institute of South Florida
    Delray Beach, Florida 33484, United States
    Active, not recruiting

    Not enrolling at this site.

  • Suburban Orthopaedics
    Bartlett, Illinois 60103, United States
    Terminated

    Not enrolling at this site.

  • Indiana Spine Group
    Carmel, Indiana 46032, United States
    Withdrawn

    Not enrolling at this site.

  • DK Orthopedics
    Crown Point, Indiana 46307, United States
    Completed

    Not enrolling at this site.

  • Lindner Center for Research & Education at The Christ Hospit
    Cincinnati, Ohio 45219, United States
    Active, not recruiting

    Not enrolling at this site.

  • STENUM Ortho Fachklinik
    Ganderkesee, 27777, Germany
    Withdrawn

    Not enrolling at this site.

  • Wirbelsäulenzentrum Fulda | Main | Kinzig
    Gelnhausen, 63571, Germany
    Active, not recruiting

    Not enrolling at this site.

  • Katholisches Klinikum Koblenz - Montabaur
    Koblenz, D-56073, Germany
    Withdrawn

    Not enrolling at this site.

  • St. Christopherus Krankenhaus - Katholisches Klinikum
    Werne, 59368, Germany
    Withdrawn

    Not enrolling at this site.

  • Hospital Nacional de Parapléjicos
    Toledo, 45004, Spain
    Recruiting
    • María Elena Alonso · Contact34 925 24 77 00
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share IPD

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04176562
Lead sponsor
Xtant Medical
Responsible party
Sponsor
First posted
Nov 25, 2019
Start date
Jan 28, 2020
Primary completion
Mar 2025 (estimated)
Completion
Jun 2025 (estimated)
Last update
Mar 12, 2024

Study contacts

Isabella M Rosales, BS
Contact
irosales@xtantmedical.com
406-924-5884
Laura Henderson
Contact
lhenderson@xtantmedical.com
406-813-4107

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion